These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25476527)

  • 1. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.
    Wang J; Chakrabarty S; Bui Q; Ruf W; Samad F
    Am J Pathol; 2015 Feb; 185(2):524-35. PubMed ID: 25476527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathways linking obesity and inflammation.
    Ruf W; Samad F
    Hamostaseologie; 2015; 35(3):279-83. PubMed ID: 25623940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
    Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation.
    Badeanlou L; Furlan-Freguia C; Yang G; Ruf W; Samad F
    Nat Med; 2011 Oct; 17(11):1490-7. PubMed ID: 22019885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
    Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
    J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.
    Kassel KM; Owens AP; Rockwell CE; Sullivan BP; Wang R; Tawfik O; Li G; Guo GL; Mackman N; Luyendyk JP
    Am J Pathol; 2011 Nov; 179(5):2278-89. PubMed ID: 21907177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, obesity, and thrombosis.
    Samad F; Ruf W
    Blood; 2013 Nov; 122(20):3415-22. PubMed ID: 24092932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition.
    Huang H; Lee SH; Sousa-Lima I; Kim SS; Hwang WM; Dagon Y; Yang WM; Cho S; Kang MC; Seo JA; Shibata M; Cho H; Belew GD; Bhin J; Desai BN; Ryu MJ; Shong M; Li P; Meng H; Chung BH; Hwang D; Kim MS; Park KS; Macedo MP; White M; Jones J; Kim YB
    J Clin Invest; 2018 Dec; 128(12):5335-5350. PubMed ID: 30226474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice.
    Kim DH; Lee B; Lee J; Kim ME; Lee JS; Chung JH; Yu BP; Dong HH; Chung HY
    Redox Biol; 2019 Jun; 24():101184. PubMed ID: 30974318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy.
    Kim BM; Kim DH; Park YJ; Ha S; Choi YJ; Yu HS; Chung KW; Chung HY
    J Nutr Biochem; 2021 Sep; 95():108769. PubMed ID: 34000413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.
    Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D
    Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
    Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic domain of tissue factor promotes liver fibrosis in mice.
    Knight V; Lourensz D; Tchongue J; Correia J; Tipping P; Sievert W
    World J Gastroenterol; 2017 Aug; 23(31):5692-5699. PubMed ID: 28883694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARD3 deficiency exacerbates diet-induced obesity, hepatosteatosis, and insulin resistance in male mice.
    Wang XA; Deng S; Jiang D; Zhang R; Zhang S; Zhong J; Yang L; Wang T; Hong S; Guo S; She Z; Zhang XD; Li H
    Endocrinology; 2013 Feb; 154(2):685-97. PubMed ID: 23321697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kupffer cell activation is a causal factor for hepatic insulin resistance.
    Lanthier N; Molendi-Coste O; Horsmans Y; van Rooijen N; Cani PD; Leclercq IA
    Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G107-16. PubMed ID: 19875703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.